ICD-10-PCS Billable Code

C51R1ZZ

Planar Nuclear Medicine Imaging Central Veins to None with None, Technetium 99m (Tc-99m) Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionC Nuclear Medicine
Body System5 Veins
Operation1 Planar Nuclear Medicine Imaging
Body PartR Central Veins
Approach1 Technetium 99m (Tc-99m)
DeviceZ None
QualifierZ None

Operation Definition

Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions

Procedure Overview

Planar nuclear medicine imaging of the veins, commonly known as a radionuclide venogram, is a test that traces how blood moves through the venous system using a radioactive tracer rather than x-ray dye. The tracer is injected into a vein, usually in the foot or hand, and a gamma camera captures a series of single-plane pictures as it travels upward through the leg or arm veins toward the heart.

The main reason this study is ordered is to look for blood clots, particularly deep vein thrombosis, in patients who cannot safely receive iodinated contrast dye used in a standard CT or catheter venogram, such as those with kidney disease or contrast allergies. A clot shows up as an area where the tracer fails to move through normally or pools abnormally. Because the images are single-plane rather than three-dimensional, the test gives a good overall picture of venous flow patterns without the added time and complexity of tomographic reconstruction.

Anatomy & Axis Detail

Central Veins

The central veins - principally the superior vena cava and the brachiocephalic veins where the extremity veins converge before reaching the heart - are imaged when peripheral studies or clinical signs such as facial swelling, neck vein distension, or bilateral arm edema suggest obstruction proximal to the extremities themselves. Malignancy, fibrosis, and long-standing central catheters or pacemaker leads are common causes of narrowing or occlusion at this level, and because these vessels lie deep within the thorax they are not as readily assessed by physical exam or extremity ultrasound. Planar imaging that follows tracer as it reaches this central confluence helps confirm the presence and extent of an occlusion and can demonstrate the collateral venous channels that form around superior vena cava syndrome.

Radionuclide: Technetium 99m (Tc-99m)

Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.

Coding & Documentation

Coders should confirm from the report that the images obtained were flat, single-plane pictures rather than a rotating tomographic acquisition, since both techniques are available for venous studies and are coded under different root operations. Documentation should also identify the injection site and the venous territory studied, since this affects body part selection. A frequent error is coding a venous nuclear study the same way as a routine contrast venogram performed in interventional radiology; the two use entirely different sections of the classification because one uses radioactive tracer and a gamma camera while the other uses iodinated dye and fluoroscopy.

Commonly Confused With

This is most often confused with conventional contrast venography, which is coded under Fluoroscopy rather than Nuclear Medicine because it relies on radiopaque dye and x-ray imaging instead of a radioactive tracer. It can also be confused with Tomographic Nuclear Medicine Imaging of the veins, which produces a three-dimensional reconstruction rather than a series of flat images; the distinction rests entirely on whether the acquisition method was planar or tomographic, as documented in the imaging report.